Sept. 16, 2025 — PaceMate has appointed Sean Shoffstall as Head of AI, Innovation and Data Strategy. Shoffstall joins PaceMate after holding senior roles with Beginly Health, Welby Health and Auditdata, where he played an integral part in the launch of the first HIPAA-compliant AI-generated audiogram analysis tool in the industry. In his new role at PaceMate, he will drive the company’s AI ambitions forward with a focus on transforming data-driven insights into automatic actions, beginning with the transformation of manual workflows that slow down clinics and take up time that could be better spent on patients.
For more than a decade, PaceMate has centralized discrete data from a wide range of cardiac monitoring devices, EHR systems and clinics’ internal operations, offering clinicians a holistic view of everything they need to deliver the best possible patient care – and actionable insights to do it far more efficiently. For PaceMate, this work has resulted in one of the most robust cardiac datasets on the planet. It’s upon this data rich-backdrop that the company will now set out to introduce a number of AI and machine learning applications that will take these operational efficiencies from streamlined to scale. Doing so will require FDA approval and HIPAA compliance that have so far hindered the introduction of AI solutions to the remote cardiac monitoring space.
To naturally progress the evolution of PaceMate’s platform, Shoffstall will drive forward an AI roadmap with an initial focus on three core areas: 1) surfacing the insights that matter most, with the necessary urgency, 2) optimizing clinics’ operational efficiency and care, and 3) fueling medical and industry research.
Since its founding, PaceMate’s innovation roadmap has been shaped by the clinicians and care teams who directly rely on it. Shoffstall seeks to maintain this approach by partnering directly with some of the more than 1,000 clinics that already trust PaceMate to streamline their remote cardiac monitoring workflows. He will lean on his decades of experience in healthcare technology to innovate responsibly with ethical AI practices and transparency at the core. Of utmost priority is ensuring that new AI applications handle the data analysis and pattern recognition enabling healthcare providers to spend more time doing what they do best: caring for patients. This includes enhancing the everyday workflows and the clinical demands of cardiac care, rather than focus on futuristic use cases that don’t meet clinics’ real-world needs.
“The amount of data that PaceMate is sitting on to drive better outcomes is very exciting when viewed from an AI standpoint. And the remote cardiac monitoring space is overdue for AI applications that are regulated and safe for physicians to use in their daily workstreams,” said Shoffstall. “PaceMate has been producing clinic-level insights for years. With AI, we’ll now be able to give practitioners the option to act on some of them to automatically cut down their daunting workloads. And we’ll put historical and industry insights to work to progress healthcare at large. I’m honored to join PaceMate at this critical moment and look forward to working in tandem with the team and clients to define the next stage of remote cardiac monitoring.”
“At PaceMate we’re dedicated to providing clinicians the software and services they need to provide the best patient care while overcoming legacy remote cardiac monitoring and operational roadblocks," said PaceMate CEO JR Finkelmeier. “Our natural next move is layering AI and machine learning capabilities on top of our data in a way that allows us to improve triage, enable population health, and even fuel preventive strategies. Shoffstall brings deep expertise in delivering such purpose-built solutions and is acutely aware of data sensitivities in the healthcare industry that can stand in the way of meeting regulatory requirements.”
PaceMate’s AI investments are the next natural step toward its commitment to streamlining workflows for cardiac clinics.
For more information, please visit pacemate.com.
September 24, 2025 
